ARTICLE | Clinical News
NeuraCeq [18F]-florbetaben regulatory update
March 3, 2014 8:00 AM UTC
The European Commission approved NeuraCeq [18F]-florbetaben from Piramal for PET imaging of beta amyloid neuritic plaque density in adults with cognitive impairment who are being evaluated for Alzhei...